# Ticagrelor Versus Cilostazol in Ischemic Stroke

> **NCT06561867** · PHASE3 · RECRUITING · sponsor: **Kafrelsheikh University** · enrollment: 900 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Ticagrelor 90 MG
- **DRUG:** Cilostazol 100 MG

## Key facts

- **NCT ID:** NCT06561867
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-30
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-20
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06561867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06561867, "Ticagrelor Versus Cilostazol in Ischemic Stroke". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06561867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*